The Department of the Army Medical Command awarded a $909,291 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Texas A&M University System Health Science Center, Finance And Business Services Division for the project "INNATE AND ADAPTIVE IMMUNE MECHANISMS OF CD74 IN POST-TRAUMATIC EPILEPSY". The grant will fund research over a 3-year period from Sep 2024 to Sep 2027 to investigate the role of the CD74 protein in the development of...
The Department of the Army Medical Command awarded $745,304 to Texas A&M University Health Science Center under the Military Medical Research and Development program (CFDA 12.420) to support the project "Epigenetic Therapy for Post-Traumatic Epilepsy" from September 30, 2022 through September 29, 2025. The project aims to develop innovative medical solutions for traumatic brain injury through basic, applied, and advanced biomedical research investigating epigenetic approaches to...
The federal Project Grant award of $1,001,000.00 was provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on September 30, 2025, supports ENDOCANNABINOID MECHANISMS OF POST-TRAUMATIC EPILEPSY research conducted by the Texas A & M University System Health Science Center (TAMU HSC) in College Station, TX. The research aims to advance understanding of medical solutions for addressing post-traumatic...
The Defense Health Agency has awarded a $760,844.00 Project Grant to the Texas A&M University System Health Science Center to conduct research under the Military Medical Research and Development program (CFDA 12.420). The three-year grant, awarded on September 15, 2023 with a completion date of September 14, 2026, will fund research titled "Targeting the MIF/CD74 Immune Axis to Treat GWI Astrocyte, Neuronal, and Cognitive Dysfunction." This research aims to investigate medical...
The Defense Health Agency awarded a $999,784 Project Grant to the Texas A&M University System Health Science Center (TAMU HSC) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, with a performance period from February 1, 2025 to January 31, 2028, will support TAMU HSC's research on "Circadian Dysregulation as a Risk Factor for Age-Related Cognitive Impairment." The research aims to investigate innovative approaches to addressing...
This $839,745 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) aims to improve care and outcomes for veterans with post-traumatic epilepsy. The grant was awarded to Baylor College of Medicine, a private health sciences university in Houston, Texas, to conduct research and develop new treatments in this area over the 3-year performance period from May 1, 2024 to April 30, 2027. As a leading academic medical center, Baylor...
The federal Project Grant award of $488,086.00, with a performance period from May 1, 2025 to April 30, 2027, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public, with a particular emphasis on conditions relevant to military personnel and veterans. The award was granted to The Henry M....
The federal Project Grant award of $860,998.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award will fund advanced biomedical research focused on the "Neurophysiology of Post-Traumatic Epilepsy: Unraveling Epileptogenesis Signals Biomarkers" at the University of California, San Francisco (UCSF) from April 1, 2025 to March 31, 2028. UCSF, a prominent academic medical center and research...
This $1,224,089 Department of Defense Project Grant awarded on September 30, 2023 to Texas A&M University System Health Science Center will fund a 3-year research project titled "CONTRIBUTION OF CELLULAR SENESCENCE AND BRAIN AGING TO COGNITIVE DYSFUNCTION IN GWI". The project will be conducted under the Department of Defense's Military Medical Research and Development program (CFDA 12.420), which supports a broad range of biomedical research to transform healthcare for Service...
The Department of the Army Medical Command awarded a $3,099,990 project grant to the Western Institute For Veterans Research under the Military Medical Research and Development program (CFDA 12.420). The grant will fund the MILITARY INJURIES - UNDERSTANDING POST-TRAUMATIC EPILEPSY (MINUTE): BIOINFORMATICS WITH BIG DATA TO EXAMINE MULTIMODAL PTE BIOMARKERS project from September 30, 2021 through September 29, 2025. The project aims to utilize bioinformatics and big data approaches to examine...